Ravi Anand
Chief Tech/Sci/R&D Officer at NEWRON PHARMACEUTICALS S.P.A.
Profile
Ravi Anand is currently the Chief Medical Officer at Newron Pharmaceuticals SpA since 2005.
Previously, he worked as the Medical Director-CNS & Clinical Research at Sandoz Research Institute from 1993 to 1997.
He then served as the International Head-CNS Medical Affairs at Sandoz, Inc. in 2001.
Dr. Anand also held the position of Head-CNS Medical Affairs at Novartis AG from 1997 to 2001.
Additionally, he worked as the Global Head-CNS Clinical Research at Organon NV from 2001 to 2003.
Dr. Anand was also the Head-CNS Medical Affairs at Elanco Italia SpA from 1997 to 2001.
Prior to his current role, he was the Head-Regulatory Affairs at F.
Hoffmann-La Roche Ltd.
Ravi Anand active positions
| Companies | Position | Start |
|---|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Chief Tech/Sci/R&D Officer | 01/01/2005 |
Former positions of Ravi Anand
| Companies | Position | End |
|---|---|---|
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Corporate Officer/Principal | 01/01/2003 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/01/2001 |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Corporate Officer/Principal | 01/01/2001 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2001 |
| Sandoz Research Institute | Corporate Officer/Principal | 01/01/1997 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
| Private companies | 5 |
|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |
| Sandoz Research Institute | |
Elanco Italia SpA
Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Health Technology |
- Stock Market
- Insiders
- Ravi Anand
